Alterity Therapeutics (ATHE) Assets Average (2009 - 2025)

Alterity Therapeutics' Assets Average history runs 16 years deep, the most recent figure standing at $33.4 million for Q4 2025.

• In Q4 2025, Assets Average rose 241.65% year-over-year to $33.4 million; the TTM figure through Dec 2025 stood at $33.4 million (up 241.65% YoY), while the FY2023 annual figure was $14.9 million, down 46.12% from the prior year.
• Assets Average was $33.4 million for Q4 2025 at Alterity Therapeutics, up from $18.2 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $33.4 million in Q4 2025 to a low of $9.8 million in Q4 2024.
• Historically, Assets Average has averaged $22.4 million across 5 years, with a median of $22.9 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Assets Average tumbled 40.17% in 2024, then jumped 241.65% in 2025.
• A 5-year view of Assets Average shows it stood at $29.3 million in 2021, then declined by 12.01% to $25.8 million in 2022, then plunged by 36.57% to $16.4 million in 2023, then sank by 40.17% to $9.8 million in 2024, then surged by 241.65% to $33.4 million in 2025.
• The last three Assets Average figures came in at $33.4 million (Q4 2025), $18.2 million (Q2 2025), and $9.8 million (Q4 2024), per Business Quant data.